Linvoseltamab

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Arms / Cohorts

Experimental:Cohort 1: Linvoseltamab + Daratumumab

Accepting patients

Experimental:Cohort 2: Linvoseltamab + Carfilzomib

Accepting patients

Experimental:Cohort 3: Linvoseltamab + Lenalidomide

Accepting patients

Experimental:Cohort 4: Linvoseltamab + Bortezomib

Accepting patients

Experimental:Cohort 5: Linvoseltamab + Pomalidomide

Accepting patients

Experimental:Cohort 6: Linvoseltamab + Isatuximab

Accepting patients

Experimental:Cohort 7: Linvoseltamab + Fianlimab

Accepting patients

Experimental:Cohort 8: Linvoseltamab + Cemiplimab

Accepting patients

Experimental:Cohort 9: Linvoseltamab + Nirogacestat

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.